p53 codon 72 polymorphism and its association with bladder cancer

Cancer Letters

Volumn 179, Issue 2, 2002, Pages 175-183

  Soulitzis, Nikolaos ^a   Sourvinos, George ^a   Dokianakis, Despina N ^a   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Bladder cancer; Codon 72 polymorphism; Human papilloma virus; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CLINICAL ARTICLE; CODON; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; CODON; DNA, NEOPLASM; DNA, VIRAL; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; URINARY BLADDER NEOPLASMS;

PAPILLOMAVIRUS;

EID: 0037188426     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00867-9     Document Type: Article

References (43)

1. Cancer statistics, 2001
2. Urothelial tumors of the urinary tract
3. Epidemiology and biology of human urinary bladder cancer
4. Papillomavirus infections - A major cause of human cancers
5. Human papillomavirus-associated tumors of the skin and mucosa
6. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
7. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
8. Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer
9. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: Evaluation by differential polymerase chain reaction
10. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients
11. Low frequency of human papillomavirus infection in initial papillary bladder tumors
12. The p53 pathway and apoptosis
13. p53, the cellular gatekeeper for growth and division
14. Prognostic significance of mutations in the p53 gene in superficial bladder cancer
15. A hot spot for p53 mutation in transitional cell carcinoma of the bladder: Clues to the etiology of bladder cancer
16. Frequent association of p53 gene mutation in invasive bladder cancer
17. p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy
18. Primary structure polymorphism at amino acid residue 72 of human p53
19. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
20. Codon 72 polymorphism of p53 and its association with cervical cancer
21. p53 polymorphism and risk of cervical cancer
22. p53 codon 72 polymorphism and risk of cervical cancer in UK
23. No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck
24. p53 polymorphism in human papillomavirus-associated esophageal cancer
25. The p53 codon 72 polymorphism and lung cancer risk
26. p53 codon 72 polymorphism as a risk factor in the development of breast cancer
27. p53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts
28. p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours
29. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes
30. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation
31. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development
32. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy
33. p53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer
34. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women
35. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes
36. Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus
37. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears
38. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
39. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants
40. Identification of a novel p53 functional domain that is necessary for efficient growth suppression
41. The polyproline region of p53 is required to activate apoptosis but not growth arrest
42. Two polymorphic variants of wild-type p53 differ biochemically and biologically
43. Is p53 polymorphism maintained by natural selection?